Skip to main content
Hester Biosciences Ltd logo

Hester Biosciences Ltd — Investor Relations & Filings

Ticker · HESTERBIO ISIN · INE782E01017 LEI · 984500836B9EB1DC4935 BSE.NS Manufacturing
Open in API
Filings indexed 672 across all filing types
Latest filing 2023-10-30 Call Transcript
Country IN India
Listing BSE.NS HESTERBIO

About Hester Biosciences Ltd

https://www.hester.in/

Hester Biosciences Ltd specializes in the development, manufacturing, and marketing of animal healthcare products. The company primarily focuses on two segments: poultry healthcare and livestock healthcare. Its extensive product portfolio includes a wide range of live and inactivated vaccines, as well as health products such as therapeutics, herbal supplements, and disinfectants. Hester is recognized for its significant contributions to global animal disease control programs, particularly in the eradication of Peste des Petits Ruminants (PPR) and Brucellosis. The company operates advanced manufacturing facilities and maintains a robust distribution network to serve domestic and international markets. By leveraging research and development, Hester provides diagnostic services and technical support to enhance animal productivity and welfare. Its commitment to quality and innovation has established it as a key provider of biologicals and health solutions for the veterinary sector.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 90% confidence The document is a notification to stock exchanges about an upcoming earnings conference call scheduled for November 7, 2023, following the announcement of unaudited financial results for the quarter and half year ended September 30, 2023. It includes details for joining the call and contact information. The document does not contain actual financial results or detailed analysis but serves as an announcement of the event. The document length is 2072 characters, which is relatively short and consistent with an announcement rather than a full report or transcript. Therefore, this document is best classified as a Call Transcript announcement (CT) or possibly a Regulatory Filing (RNS). However, since it specifically announces an earnings conference call, the most appropriate classification is Call Transcript (CT).
2023-10-30 English
Board Meeting — HESTER BIOSCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 07-Nov-2023 to inter-alia consider and approve the Unaudited Financial results of the Company fo…
Regulatory Filings
2023-10-27 English
Board Meeting — Financial Results
Board/Management Information Classification · 95% confidence The document is a short notice informing stock exchanges about an upcoming Board Meeting scheduled for 7 November 2023. The purpose of the meeting includes consideration of the standalone and consolidated unaudited financial results for the quarter and half year ended 30 September 2023. The document is an intimation or announcement of a future event (Board Meeting) rather than the actual financial results or report. It references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, which governs disclosures related to board meetings. The document length is only 1071 characters, indicating it is a brief announcement. According to the classification rules, such a notice about a board meeting is best classified under Board/Management Information (MANG).
2023-10-27 English
Updates
Regulatory Filings Classification · 95% confidence The document is a confirmation certificate addressed to stock exchanges regarding securities dematerialised/rematerialised during the quarter ended 30 September 2023. It references compliance with SEBI regulations and includes a confirmation certificate from the Registrar and Share Transfer Agent. The document length is short (1183 characters) and it primarily serves as a regulatory compliance communication rather than a financial report or detailed filing. It does not contain financial statements, management discussion, or detailed report data. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and confirmations that do not fit other specific categories.
2023-10-09 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notification about the closure of the trading window in compliance with SEBI (Prohibition of Insider Trading) Regulations. It informs the stock exchanges about the trading restrictions around the release of quarterly and half-year financial results. The document does not contain any financial data, report content, or detailed analysis. It is a regulatory announcement related to insider trading compliance and trading restrictions, not a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS). The document length is short and it is an announcement rather than a report itself.
2023-09-29 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a notification addressed to stock exchanges regarding the loss of share certificates by a shareholder, pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It requests caution to prevent trading or dealing in the lost share certificates. The content is a regulatory compliance announcement related to share certificate loss, not a financial report, earnings release, or management information. It does not contain financial data or detailed report content. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-09-25 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.